Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes

Diabetes

Volumn 56, Issue 6, 2007, Pages 1686-1693

  Ueno, Aito ^a   Cho, Suzanne ^a   Cheng, Lu ^a   Wang, Jianxiong ^a   Hou, Sheng ^a   Nakano, Hiroko ^a   Santamaria, Pere ^a   Yang, Yang ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; RECOMBINANT CHORIONIC GONADOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DIABETOGENESIS; DISEASE COURSE; DRUG MECHANISM; ENZYME INHIBITION; ENZYME REGULATION; HORMONE ACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOPHARMACOLOGY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHORIONIC GONADOTROPIN; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-10; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, KNOCKOUT;

EID: 34249695524     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1727     Document Type: Article

References (35)

1. Eisenbarth GS: Type 1 diabetes: molecular, cellular and clinical immunology. Adv Exp Med Biol 552:306-310, 2004
2. Zhang Y, O'Brien B, Trudeau J, Tan R, Santamaria P, Dutz JP: In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol 168:1466-1472, 2002
3. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D: Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189:331-339, 1999
4. Grohmann U, Fallarino F, Bianchi R, Orabona C, Vacca C, Fioretti MC, Puccetti P: A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 198:153-160, 2003
5. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL: GCN2 kinase in T-cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22:633-642, 2005
6. Mellor AL, Munn DH: IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762-774, 2004
7. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC, Puccetti P: CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3:1097-1101, 2002
8. Hayashi T, Beck L, Rossetto C, Gong X, Takikawa O, Takabayashi K, Broide DH, Carson DA, Raz E: Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 114:270-279, 2004
9. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L: Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310:850-855, 2005
10. Sakurai K, Zou JP, Tschetter JR, Ward JM, Shearer GM: Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 129:186-196, 2002
11. Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF: Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125:1762-1773, 2003
12. Mackler AM, Barber EM, Takikawa O, Pollard JW: Indoleamine 2,3-dioxygenase is regulated by IFN-γ in the mouse placenta during Listeria monocytogenes infection. J Immunol 170:823-830, 2003
13. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193, 1998
14. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH: Prevention of T-cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64-68, 2001
15. Sedlmayr P, Blaschitz A, Wintersteiger R, Semlitsch M, Hammer A, MacKenzie CR, Walcher W, Reich O, Takikawa O, Dohr G: Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol Hum Reprod 8:385-391, 2002
16. Kudo Y, Boyd CA, Spyropoulou I, Redman CW, Takikawa O, Katsuki T, Hara T, Ohama K, Sargent IL: Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta. J Reprod Immunol 61:87-98, 2004
17. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL: Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 61:67-77, 2004
18. Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, Takikawa O, Saito S: IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-{gamma} increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod, 2006
19. Alfthan H, Stenman UH: Pathophysiological importance of various molecular forms of human choriogonadotropin. Mol Cell Endocrinol 125:107-120, 1996
20. Srisuparp S, Strakova Z, Fazleabas AT: The role of chorionic gonadotropin (CG) in blastocyst implantation. Arch Med Res 32:627-634, 2001
21. Rao CV: An overview of the past, present, and future of nongonadal LH/hCG actions in reproductive biology and medicine. Semin Reprod Med 19:7-17, 2001
22. Khan NA, Khan A, Savelkoul HF, Benner R: Inhibition of diabetes in NOD mice by human pregnancy factor. Hum Immunol 62:1315-1323, 2001
23. Anderson B, Park BJ, Verdaguer J, Amrani A, Santamaria P: Prevalent CD8(+) T-cell response against one peptide/MHC complex in autoimmune diabetes. Proc Natl Acad Sci U S A 96:9311-9316, 1999
24. Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, Wilson DB: Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T-cells from transgenic BDC2.5 nonobese diabetic mice. J Immunol 166:908-917, 2001
25. Serreze DV, Chapman HD, Post CM, Johnson EA, Suarez-Pinzon WL, Rabinovitch A: Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol 166:1352-1359, 2001
26. Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A: Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol 171:2305-2313, 2003
27. Alexander AM, Crawford M, Bertera S, Rudert WA, Takikawa O, Robbins PD, Trucco M: Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51:356-365, 2002
28. Trowsdale J, Betz AG: Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 7:241-246, 2006
29. Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T-cells mediate maternal tolerance to the fetus. Nat Immunol 5:266-271, 2004
30. Keay SD, Vatish M, Karteris E, Hillhouse EW, Randeva HS: The role of hCG in reproductive medicine. Bjog 111:1218-1228, 2004
31. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S: Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 22:234-241, 2006
32. Vukusic S, Confavreux C: Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg 108:266-270, 2006
33. Maghnie M, Valtorta A, Moretta A, Priora C, Preti P: [Effects of chorionic gonadotropin (hCG) therapy on the immune system]. Medicina (Firenze) 10:148-149, 1990
34. Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL: Active specific immunotherapy with a β-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res 8:2044-2051, 2002
35. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL: Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114:280-290, 2004